| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.097 | 0.6 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.6 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.6 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |